Tag: survival_rate

Experimental Drug Doubles Survival for Metastatic Pancreatic Cancer

9 Jun 2026 7:01 a.m.

A new experimental drug has demonstrated remarkable success, doubling the median survival rate for patients with metastatic pancreatic cancer. This breakthrough offers a dramatic shift in treatment, bringing renewed hope to those affected.

Health Business Science & Technology Entertainment Medical Science Economy Employment and Labor Education Pancreatic Cancer Metastatic Cancer Experimental Drug Cancer Treatment Medical Research Survival Rate Oncology